Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder

Clinical trial NCT00139919 · COMPLETED

Trial details

NCT number: NCT00139919
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar Disorder

Start date: 2006-01-01
Primary completion: 2007-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.